14.11
+0.04
+(0.28%)
At close: April 17 at 5:35:09 PM GMT+2
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-11,922
-11,922
-21,005
-21,362
-12,134
Investing Cash Flow
-613
-613
1,298
-316
-1,062
Financing Cash Flow
25,528
25,528
1,556
-800
47,917
End Cash Position
19,460
19,460
6,467
24,617
47,095
Capital Expenditure
-1,191
-1,191
-1,027
-1,974
-819
Issuance of Capital Stock
23,321
23,321
810
48
42,285
Issuance of Debt
13,843
13,843
29,976
3,308
18,706
Repayment of Debt
-8,767
-8,767
-24,148
-2,307
-9,265
Repurchase of Capital Stock
-25
-25
--
-192
--
Free Cash Flow
-13,113
-13,113
-22,032
-23,336
-12,953
3/31/2021 - 10/8/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4588.T Oncolys BioPharma Inc.
579.00
+6.04%
4565.T Nxera Pharma Co., Ltd.
850.00
+3.41%
4587.T PeptiDream Inc.
1,870.00
+3.03%
ALCLS.PA Cellectis S.A.
1.3500
+0.15%
DBV.PA DBV Technologies S.A.
1.3280
+3.59%
ADOC.PA Adocia SA
3.8500
+2.67%
BSLN.SW Basilea Pharmaceutica AG
41.30
-0.96%
CAMX.ST Camurus AB (publ)
566.00
+0.62%
PRTC PureTech Health plc
16.74
+0.02%
GLPG.AS Galapagos NV
21.84
+0.74%